fluorodeoxyglucose f18 has been researched along with hydromethylthionine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentham, P; Gauthier, S; Kook, K; Miller, S; Schelter, BO; Wischik, CM | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and hydromethylthionine
| Article | Year |
|---|---|
Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate.
Topics: Activities of Daily Living; Alzheimer Disease; Atrophy; Fluorodeoxyglucose F18; Humans; Mesylates | 2022 |